ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698379 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698379; 2) Community: the network communities that were significantly associated with the response to NSC 698379; 3) Molecule: the relationships between components within communities and NSC 698379; 4) MDR: the compounds that were significantly associated with the NSC 698379.

NSC Compound Enrichment Correlation
NSC 698057 Null 0.0312262198176283 0.53911959
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0352383000003056 0.20799375
NSC 154948 M-AMSA 0.0352383000003056 0.0093173827
NSC 18805 .gamma.-Thujaplicine 0.0352383000003056 0.32130542
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0352383000003056 0.11584532
NSC 303861 L-Cysteine analog 0.0352383000003056 0.51343009
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0352383000003056 0.223415
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0352383000003056 0.2431818
NSC 371777 Null 0.0352383000003056 0.18660905
NSC 409749 Null 0.0352383000003056 0.4643571
Total:99  Current:71    [First] [Prev] [Next] [Last]